Emb Therapeutics Inc is categorized under Biotherapeutics in New York City, NY and active since 2000.
Emb Therapeutics Inc was established in 2000, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Biotherapeutics business, which does work in the BOTH market, and is classified as a Biotherapeutics, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Virgie Bright, Owner at the company’s single location by writing to 110 West 118th St, New York City, New York NY 10026 or by phoning (212) 932-1911. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Emb Therapeutics Inc |
| Contact Person: | Virgie Bright, Owner |
| Address: | 110 West 118th St, New York City, New York 10026 |
| Phone Number: | (212) 932-1911 |
| Website Address: | getaclearshave.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | Biotherapeutics |
| SIC Code: | 5122 |
| NAICS Code: | 4242101 |
| Share This Business: |
Emb Therapeutics Inc was started in 2000 to provide professional Biotherapeutics under the SIC code 5122 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Virgie Bright, Owner for inquiries that concern Emb Therapeutics Inc by calling the company number (212) 932-1911, as your correspondence is most welcome. Additionally, the physical location of the single location of Emb Therapeutics Inc can be found at the coordinates 40.803871,-73.950156 as well as the street address 110 West 118th St in New York City, New York 10026.
For its online presence, you may visit Emb Therapeutics Inc’s website at getaclearshave.com and engage with its social media outlets through on Twitter and on Facebook.